Epidiolex Advisory Committee Appears To Be Covering US FDA's Bases, But Liver Injury Concerns Persist

 
• By Michael Cipriano
  
Airliner in flight
It looks like clear skies for GW Pharmaceuticals's childhood epilepsy drug Epidiolex (cannabidiol).
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers